Effects of l-arginine supplementation on blood flow, oxidative stress status and exercise responses in young adults with uncomplicated type i diabetes

European Journal of Nutrition

Volumn 52, Issue 3, 2013, Pages 975-983

  Fayh, Ana Paula Trussardi ^a   Krause, Mauricio ^b,c   Rodrigues Krause, Josianne ^b,c   Ribeiro, Jerri Luiz ^d   Ribeiro, Jorge Pinto ^e   Friedman, Rogério ^e   Moreira, José Cláudio Fonseca ^a   Reischak Oliveira, Alvaro ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d Instituto Metodista Porto Alegre   (Brazil)

^e HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Blood flow; l Arginine; Oxidative stress; Type 1 diabetes

Indexed keywords

ARGININE; CARBONYL DERIVATIVE; PLACEBO; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEG BLOOD FLOW; MALE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PHYSICAL CAPACITY; TREATMENT DURATION;

ADOLESCENT; ADULT; ARGININE; BIOLOGICAL MARKERS; BLOOD CIRCULATION; BRAZIL; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; EXERCISE TEST; HUMANS; LOWER EXTREMITY; MALE; MOTOR ACTIVITY; OXIDATIVE STRESS; REGIONAL BLOOD FLOW; RISK FACTORS; YOUNG ADULT;

EID: 84879551057     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-012-0404-7     Document Type: Article

References (50)

1. Melendez-Ramirez LY, Richards RJ, Cefalu WT (2010) Complications of type 1 diabetes. Endocrinol Metab Clin North Am 39:625-640
2. Huysman E, Mathieu C (2009) Diabetes and peripheral vascular disease. Acta Chir Belg 109:587-594
3. Krause Mda S, De Bittencourt PI Jr (2008) Type 1 diabetes: can exercise impair the autoimmune event? The l-arginine/glutamine coupling hypothesis. Cell Biochem Funct 26:406-433
4. Poston L, Taylor PD (1995) Glaxo/MRS young investigator prize. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin Sci (Lond) 88:245-255
5. Meeking DR, Browne DL, Allard S, Munday J, Chowienczyck PJ, Shaw KM, Cummings MH (2000) Effects of cyclo-oxygenase inhibition on vasodilatory response to acetylcholine in patients with type 1 diabetes and nondiabetic subjects. Diabetes Care 23:1840-1843
6. Newsholme P, Homem De Bittencourt PI, C OH, De Vito G, Murphy C, Krause MS (2009) Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide. Clin Sci (Lond) 118:341-349
7. Barbul A (1986) Arginine: biochemistry, physiology, and therapeutic implications. JPEN J Parenter Enteral Nutr 10:227-238
8. Flynn NE, Meininger CJ, Haynes TE, Wu G (2002) The metabolic basis of arginine nutrition and pharmacotherapy. Biomed Pharmacother 56:427-438
9. Maxwell AJ (2002) Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. Nitric Oxide 6:101-124
10. El-Missiry MA, Othman AI, Amer MA (2004) l-Arginine ameliorates oxidative stress in alloxan-induced experimental diabetes mellitus. J Appl Toxicol 24:93-97
11. Krause MS, McClenaghan NH, Flatt PR, de Bittencourt PI, Murphy C, Newsholme P (2011) l-arginine is essential for pancreatic beta-cell functional integrity, metabolism and defense from inflammatory challenge. J Endocrinol 211:87-97
12. Fu WJ, Haynes TE, Kohli R, Hu J, Shi W, Spencer TE, Carroll RJ, Meininger CJ, Wu G (2005) Dietary l-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr 135:714-721
13. Vasilijevic A, Buzadzic B, Korac A, Petrovic V, Jankovic A, Korac B (2007) Beneficial effects of l-arginine nitric oxide-producing pathway in rats treated with alloxan. J Physiol 584:921-933
14. Mendez JD, Balderas F (2001) Regulation of hyperglycemia and dyslipidemia by exogenous l-arginine in diabetic rats. Biochimie 83:453-458
15. West MB, Ramana KV, Kaiserova K, Srivastava SK, Bhatnagar A (2008) l-Arginine prevents metabolic effects of high glucose in diabetic mice. FEBS Lett 582:2609-2614
16. Mendez JD, Hernandez Rde H (2005) l-Arginine and polyamine administration protect beta-cells against alloxan diabetogenic effect in Sprague-Dawley rats. Biomed Pharmacother 59:283-289
17. Wu G, Collins JK, Perkins-Veazie P, Siddiq M, Dolan KD, Kelly KA, Heaps CL, Meininger CJ (2007) Dietary supplementation with watermelon pomace juice enhances arginine availability and ameliorates the metabolic syndrome in Zucker diabetic fatty rats. J Nutr 137:2680-2685
18. Lucotti P, Monti L, Setola E, La Canna G, Castiglioni A, Rossodivita A, Pala MG, Formica F, Paolini G, Catapano AL, Bosi E, Alfieri O, Piatti P (2009) Oral l-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass. Metabolism 58:1270-1276
19. Settergren M, Bohm F, Malmstrom RE, Channon KM, Pernow J (2009) l-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease. Atherosclerosis 204:73-78
20. Martina V, Masha A, Gigliardi VR, Brocato L, Manzato E, Berchio A, Massarenti P, Settanni F, Della Casa L, Bergamini S, Iannone A (2008) Long-term N-acetylcysteine and l-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care 31:940-944
21. Lucotti P, Setola E, Monti LD, Galluccio E, Costa S, Sandoli EP, Fermo I, Rabaiotti G, Gatti R, Piatti P (2006) Beneficial effects of a long-term oral l-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am J Physiol Endocrinol Metab 291:E906-E912
22. Natarajan Sulochana K, Lakshmi S, Punitham R, Arokiasamy T, Sukumar B, Ramakrishnan S (2002) Effect of oral supplementation of free amino acids in type 2 diabetic patients - a pilot clinical trial. Med Sci Monit 8:CR131-137
23. Heitzer T, Krohn K, Albers S, Meinertz T (2000) Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus. Diabetologia 43:1435-1438
24. Wascher TC, Graier WF, Dittrich P, Hussain MA, Bahadori B, Wallner S, Toplak H (1997) Effects of low-dose l-arginine on insulin-mediated vasodilatation and insulin sensitivity. Eur J Clin Invest 27:690-695
25. Marwick TH, Hordern MD, Miller T, Chyun DA, Bertoni AG, Blumenthal RS, Philippides G, Rocchini A (2009) Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation 119:3244-3262
26. Palloshi A, Fragasso G, Piatti P, Monti LD, Setola E, Valsecchi G, Galluccio E, Chierchia SL, Margonato A (2004) Effect of oral l-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries. Am J Cardiol 93:933-935
27. Ceremuzynski L, Chamiec T, Herbaczynska-Cedro K (1997) Effect of supplemental oral l-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol 80:331-333
28. Bednarz B, Wolk R, Chamiec T, Herbaczynska-Cedro K, Winek D, Ceremuzynski L (2000) Effects of oral l-arginine supplementation on exercise-induced QT dispersion and exercise tolerance in stable angina pectoris. Int J Cardiol 75:205-210
29. Abdelhamed AI, Reis SE, Sane DC, Brosnihan KB, Preli RB, Herrington DM (2003) No effect of an l-arginine-enriched medical food (HeartBars) on endothelial function and platelet aggregation in subjects with hypercholesterolemia. Am Heart J 145:E15
30. Clarkson P, Adams MR, Powe AJ, Donald AE, McCredie R, Robinson J, McCarthy SN, Keech A, Celermajer DS, Deanfield JE (1996) Oral l-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest 97:1989-1994
31. Pollack ML, Schmidt DH, Jackson AS (1980) Measurement of cardio-respiratory fitness and body composition in the clinical setting. Compr Ther 6:12-27
32. Metra M, Raddino R, Dei Cas L, Visioli O (1990) Assessment of peak oxygen consumption, lactate and ventilatory thresholds and correlation with resting and exercise hemodynamic data in chronic congestive heart failure. Am J Cardiol 65:1127-1133
33. 2max criteria: discontinuous versus continuous protocols. Med Sci Sports Exerc 29:273-278
34. Dekerle J, Baron B, Dupont L, Vanvelcenaher J, Pelayo P (2003) Maximal lactate steady state, respiratory compensation threshold and critical power. Eur J Appl Physiol 89:281-288
35. Wasserman K, McIlroy MB (1964) Detecting the threshold of anaerobic metabolism in cardiac patients during exercise. Am J Cardiol 14:844-852
36. Amann M, Subudhi AW, Walker J, Eisenman P, Shultz B, Foster C (2004) An evaluation of the predictive validity and reliability of ventilatory threshold. Med Sci Sports Exerc 36:1716-1722
37. Copeland SR, Mills MC, Lerner JL, Crizer MF, Thompson CW, Sullivan JM (1996) Hemodynamic effects of aerobic vs resistance exercise. J Hum Hypertens 10:747-753
38. Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62-71
39. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
40. Draper HH, Hadley M (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421-431
41. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464-478
42. Wayner DD, Burton GW, Ingold KU, Locke S (1985) Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins. FEBS Lett 187:33-37
43. Cvetkovic T, Mitic B, Lazarevic G, Vlahovic P, Antic S, Stefanovic V (2009) Oxidative stress parameters as possible urine markers in patients with diabetic nephropathy. J Diabetes Complications 23:337-342
44. Huang EA, Gitelman SE (2008) The effect of oral alpha-lipoic acid on oxidative stress in adolescents with type 1 diabetes mellitus. Pediatr Diabetes 9:69-73
45. Harrison DG (1997) Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100:2153-2157
46. Milsom AB, Jones CJ, Goodfellow J, Frenneaux MP, Peters JR, James PE (2002) Abnormal metabolic fate of nitric oxide in type I diabetes mellitus. Diabetologia 45:1515-1522
47. Wu G, Meininger CJ (2000) Arginine nutrition and cardiovascular function. J Nutr 130:2626-2629
48. Higashi Y, Oshima T, Ono N, Hiraga H, Yoshimura M, Watanabe M, Matsuura H, Kambe M, Kajiyama G (1995) Intravenous administration of l-arginine inhibits angiotensin-converting enzyme in humans. J Clin Endocrinol Metab 80:2198-2202
49. Kilbom A, Wennmalm A (1976) Endogenous prostaglandins as local regulators of blood flow in man: effect of indomethacin on reactive and functional hyperaemia. J Physiol 257:109-121
50. Cowley AJ, Stainer K, Rowley JM, Wilcox RG (1985) Effect of aspirin and indomethacin on exercise-induced changes in blood pressure and limb blood flow in normal volunteers. Cardiovasc Res 19:177-180